AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist
  • 4.540
  • -0.010-0.22%
20min DelayNot Open Dec 13 16:00 AET
1.46BMarket Cap-29.29P/E (Static)

About Clarity Pharmaceuticals Ltd Company

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology. It operates as a single segment, which is Development of Radiopharmaceuticals. Geographically, it operates in Australia and the United States.

Company Profile

SymbolCU6
Company NameClarity Pharmaceuticals Ltd
Founded2010
MarketASX
Fiscal Year Ends06-30
Address4 Cornwallis Street National Innovation Centre
CitySydney
CountryAustralia
Zip Code2015
Phone+61 292094037
Share RegistryLINK MARKET SERVICES LIMITED LEVEL 12, 680 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000 1300 554 474

Company Executives

  • Name
  • Position
  • Salary
  • Michelle Parker
  • Director and Chief Executive Officer
  • --
  • Dr. Colin Biggin, PhD
  • Director and Chief Operating Officer
  • --
  • Dr. Thomas Ramdahl
  • Independent Director
  • --
  • Dr. Christopher G. Roberts,PhD
  • Independent Director
  • --
  • Rosanne Robinson
  • Lead Independent Director
  • --
  • Dr. Alan Taylor, PhD
  • Executive Chairperson of the Board
  • --